Alirocumab versus usual lipid-lowering care as add-on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM-DYSLIPIDEMIA randomized trial.
| Image |  |
|---|---|
| Description | scientific article published on 13 February 2018 |
| Author/s |
author: Kausik K Ray Stefano Del Prato Alexia Letierce Robert R Henry Lawrence A Leiter |
| Publication date | March 23, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |